Peyronie's disease: Lights and shadows

Urologia Internationalis

Volumn 78, Issue 1, 2007, Pages 1-9

  Sasso, F ^a   Gulino, G ^a,b   Falabella, R ^a   D'Addessi, A ^a   Sacco, E ^a   D'Onofrio, A ^a   Bassi, P F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ALPHA TOCOPHEROL; AMINOBENZOIC ACID; COLCHICINE; COLLAGENASE; DEXAMETHASONE; INTERFERON; LIDOCAINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; TAMOXIFEN; TRIAMCINOLONE; VERAPAMIL;

ACUTE DISEASE; ANAMNESIS; ARTHRALGIA; AUTOGRAFT; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG BINDING; DUPUYTREN CONTRACTURE; EVALUATION; EXTRACORPOREAL LITHOTRIPSY; GASTROINTESTINAL SYMPTOM; GENETICS; GOLD STANDARD; HEREDITY; HUMAN; INCIDENCE; INCISION; INJECTION SITE ATROPHY; INJECTION SITE FIBROSIS; IONTOPHORESIS; MALE GENITAL SYSTEM SURGERY; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT SATISFACTION; PENIS INJURY; PENIS PROSTHESIS; PEYRONIE DISEASE; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK FACTOR; SINUSITIS; SKIN GRAFT; SURGICAL TECHNIQUE; TREATMENT DURATION; XENOGRAFT;

ANTINEOPLASTIC AGENTS; HIGH-ENERGY SHOCK WAVES; HUMANS; IONTOPHORESIS; MAGNETIC RESONANCE IMAGING; MALE; PENILE INDURATION; PROGNOSIS; TUBULIN MODULATORS; ULTRASONOGRAPHY, DOPPLER; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 33845964251     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096927     Document Type: Review

References (77)

1. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U: The prevalence of Peyronie's disease: results of a large survey. BJU Int 2001;88:727-730.
2. Smith CJ, McMahon C, Shabsigh R: Peyronie's disease: the epidemiology, aetiology and clinical evaluation of deformity. BJU Int 2005;95:729-732.
3. Smith BH: Subclinical Peyronie's disease. Am J Clin Pathol 1969;52:385-390.
4. Pryor JP, Ralph DJ: Clinical presentation of Peyronie's disease. Int J Impot Res 2002;14:414-417.
5. Carreri MP, Serraino D, Palmiotto F, Nucci G, Sasso F: A case-control study on risk factors for Peyronie's disease. J Clin Epidemiol 1998;51:511-515.
6. Qian A, Meals RA, Rajfer J, Gonzales-Cadavid NF: Comparison of gene expression profiles between Peyronie's disease and Dupuyten's contracture. Urology 2004;64:399-404.
7. Rompel R, Weidner W, Mueller-Eckhardt G: HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis? Tissue Antigens 1991;38:104-106.
8. Nachtsheim DA, Rearden A: Peyronie's disease is associated with an HLA class II antigen, HLA-DQ5, implying an autoimmune etiology. J Urol 1996;156:1330-1334.
9. Gholami SS, Lue TF: Peyronie's disease. Urol Clin North Am 2001;28:377-390.
10. Schiavino D, Sasso F, Nucera E, Alcini E, Gulino G, Milani A, Patriarca G: Immunologic findings in Peyronie's disease: a controlled study. Urology 1997;50:764-768.
11. Devine CJ, Somers KD, Ladaga LE: Peyronie's disease: pathophysiology. Prog Clin Biol Res 1991;37:355-358.
12. Hellstrom WJ, Bivalacqua TJ: Peyronie's disease: etiology, medical, and surgical therapy. J Androl 2000;21:347-354.
13. Lewis RW, Jordan GH: Surgery for erectile dysfunction; in Walsh P, Retik AB, Vaughan ED, Wein AJ (eds): Cambpell's Urology, ed 8. Philadelphia, Saunders, 2002, pp 1696-1709.
14. Somers KD, Dawson DM: Fibrin deposition in Peyronie's disease plaque. J Urol 1997;157:311-315.
15. El-Sakka AI, Hassan MU, Nunes L, Bhatnagar RS, Yen TS, Lue TF: Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol 1998;81:445-452.
16. Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J, Gonzales-Cadavid NF: Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for Peyronie's disease. Biol Reprod 2005;73:1199-1210.
17. Shabsigh R, Fleming M, Perelman M, Anastasiadis A: Peyronie's Disease Index: a standardized patient questionnaire. Int J Impot Res 2003;14(Suppl 3):S68.
18. Kadioglu A, Oktar T, Kandirali E, Kendirci M, Sanli O, Ozsoy C: Incidentally diagnosed Peyronie's disease in men presenting with erectile dysfunction. J Urol 2005;173:2076-2080.
19. El Sakka A: Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol 2006;49:564-569.
20. Chilton CP, Castle WM, Westwood CA, Pryor JP: Factor associated in the aetiology of Peyronie's disease. Br J Urol 1982;54:748-750.
21. Lopez JA, Jarow JP: Penile vascular evaluation for men with Peyronie's disease. J Urol 1993;149:53-55.
22. Kendirci M, Nowfar S, Gur S, Jabren GW, Sikka SC, Hellstrom WJ: The relationship between the type of penile abnormality and penile vascular status in patients with Peyronie's disease. J Urol 2005;174:632-635.
23. Gasior BL, Levine FJ, Howannesian A, Krane RJ, Goldstein I: Plaque-associated corporal veno-occlusive dysfunction in idiopathic Peyronie's disease: a pharmacocavernosometry and pharmacocavernosographic study. World J Urol 1990;8:90-96.
24. Wilkins CJ, Sriprasad S, Sidhu PS: Colour Doppler ultrasound of the penis. Clin Radiol 2003;58:514-523.
25. Levine LA, Greenfield JM: Establishing a standardized evaluation of the man with Peyronie's disease. Int J Impot Res 2003;15(Suppl 5):S103-S112.
26. Jordan GH, Angermeier KW: Preoperative evaluation of erectile function with dynamic infusion cavernosometry/cavernosography in patients undergoing surgery for Peyronie's disease: correlation with postoperative results. J Urol 1993;150:1138-1142.
27. Hauck EW, Hackstein N, Vosshenrich R, Diemer T, Schmelz HU, Bschleipfer T, Schroeder-Printzen I, Weidner W: Diagnostic value of magnetic resonance imaging in Peyronie's disease - a comparison both with palpation and ultrasound in the evaluation of plaque formation. Eur Urol 2003;43:293-300.
28. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
29. Moncada I, Carbello R, Martinez-Salamanca JI, Monzo JI, Jara J, Hernandez C: Peyronie's disease: a review. GIMSeR 2005;12:73-83.
30. Akkus E, Carrier S, Rehman J, Breza J, Kadioglu A, Lue TF: Is colchicine effective in Peyronie's disease? A pilot study. Urology 1994;44:291-295.
31. Weidner W, Hauck EW, Schnitker J: Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study. Eur Urol 2005;47:530-536.
32. Gulino G, Colombo F, Palmieri A, Spera E, Falabella R, Sasso F: Il tamoxifene come prima terapia orale in pazienti affetti da induratio penis plastica. Studio multicentrico promosso dal Gruppo di Studio SIA sull'IPP. G Ital Androl 2001;1-2:16-20.
33. Colletta AA, Wakefield LM, Howell FW, van Roozendaal KE, Danielpour D, Ebbs SR, Sporn MB, Baum M: Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 1990;62:405-409.
34. Redman J, Benet A, Melman A: Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology 1998;51:620-626.
35. Williams G, Green NA: Then nonsurgical treatment of Peyronie's disease. Br J Urol 1980;32:392-395.
36. Gelbert MK, Walsh R, Kaufmann JJ: Collagenase for Peyronie's disease: experimental studies. Urol Res 1982;10:135-140.
37. Morales A, Bruce AW: The treatment of Peyronie's disease with parathyroid hormone. J Urol 1975;114:901-902.
38. Strebel RT, Suter S, Sautter T, Hauri D: Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity. Int J Impot Res 2004;16:448-451.
39. Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W: Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials. J Urol 2004;171(2 Pt 1):740-745.
40. Fitch W, Easterling WJ: Topical verapamil, Trifluoroperazine and magnesium sulphate for Peyronie's disease. Int J Impot Res 2001;13:S62.
41. Montorsi F, Guazzoni G, Bocciardi A, Barbieri L, et al.: Transdermal electromotive multi-drug administration for Peyronie's disease: a randomized, double-blind, placebo-controlled, partial cross-over study. J Urol 1995;153:472.
42. Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H: Iontophoresis for treatment of Peyronie's disease. J Urol 2000;163:95-99.
43. Ralph DJ, Minhas S: The management of Peyronie's disease. BJU Int 2004;93:208-215.
44. Ralph DJ, al-Akraa M, Pryor JP: The Nesbit operation for Peyronie's disease: 16-year experience. J Urol 1995;154:1362-1363.
45. Andrews OH, al-Akraa M, Pryor JP, Ralph DJ: The Nesbit operation for Peyronie's disease: an analysis of the failures. BJU Int 2001; 87:658-660.
46. Savoca G, Scieri F, Pietropaolo F, Garaffa G, Belgrano E: Straightening corporoplasty for Peyronie's disease: a review of 218 patients with median follow-up of 89 months. Int J Impot Res 2003;15:465-467.
47. Yachia D: Modified corporoplasty for the treatment of penile curvature. J Urol 1990;143:80-82.
48. Giammusso B, Burrello M, Branchina A, Nicolosi F, Motta M: Modified corporoplasty for ventral penile curvature: description of the technique and initial results. J Urol 2004;171:1209-1211.
49. Essed E, Schroeder FH: New surgical treatment for Peyronie disease. Urology. 1985;25:582-587.
50. Schultheiss D, Meschi MR, Hagemann J, Truss MC, Stief CG, Jonas U: Congenital and acquired penile deviation treated with the Essed plication method. Eur Urol 2000;38:167-171.
51. Vatne V, Hoeisaeter PA: Functional results after operations of penile deviations: an institutional experience. Scand J Urol Nephrol Suppl 1996;179:151-154.
52. Manning M, Jünemann KP, Spahn M, Alken P: Operative Korrektur der Penisverkrümmung - Indikationen und Grenzen der Schroeder-Essed-Technik. Akt Urol 1999;30:163-169.
53. van der Horst C, Martinez Portillo FJ, Melchior D, Bross S, Alken P, Jünemann KP: Polytetrafluoroethylene vs. polypropylene sutures for Essed-Schroeder tunical plication. J Urol 2003;170(2 Pt 1):472-475.
54. Gholami SS, Lue TF: Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol 2002;167:2066-2069.
55. Rehman J, Benet A, Minsky LS, Melman A: Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication). J Urol 1997;157:1288-1291.
56. Minervini A, Morelli G, Dinelli N, Selli C, Minervini R: Corporeal herniation after Nesbit plication with partial thickness shaving for congenital penile curvature. Int J Impot Res 2000;12:289-293
57. Raimoldi A, Berti GL, Giola V, Longoni E, Paccaduscio A, Pozzoni F, Russo R, Bacchioni AM: Our experience in the treatment of penile curvature. Arch Ital Urol Androl 2004;76:66-68.
58. Devin CJ, Jordan GH, Schlossberg SM: Chirurgia dell'uretra e del pene. Urol Campbell 1993;4:3149.
59. Brock G, Hsu GL, Nunes L, Von Heyden B, Lue TF: The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol 1997;157:276.
60. Kim ED, McVary KT: Long-term follow-up of treatment of Peyronie's disease with plaque incision, carbon dioxide laser plaque ablation and placement of a deep dorsal vein patch graft. J Urol 1995;153:1843-1846.
61. Chang JA, Gholami SS, Lue TF: Surgical management: saphenous vein grafts. Int J Impot Res 2002;14:375-378.
62. Bokarica P, Parazajder J, Mazuran B, Gilja I: Surgical treatment of Peyronie's disease based on penile length and degree of curvature. Int J Impot Res 2005;17:170-174.
63. Leungwattanakij S, Bivalacqua TJ, Reddy S, Hellstrom WJ: Long-term follow-up on use of pericardial graft in the surgical management of Peyronie's disease. Int J Impot Res 2001;13:183-186.
64. Cheng EY, Kropp BP: Urologic tissue engineering with small-intestinal submucosa: potential clinical applications. World J Urol 2000;18:26-30.
65. Knoll D: Use of porcine small intestinal submucosal graft in the surgical management of Peyronie's disease. Urology 2001;57:753-757.
66. Gulino G, Falabella R, Gentile G, Sasso F: Radical surgery in Peyronie's disease. Minerva Chir 2002;57:383-388.
67. Austoni E, Colombo F, Mantovani F, Patelli E, Fenice O: Radical surgery and conservation of erection in Peyronie's disease. Arch Ital Urol Androl 1995;67:359.
68. Austoni E, Colombo F, Mantovani F: Evaluation of corpora alterations and erectile dysfunction following radical surgery for Peyronie's disease and long-term follow-up on 152 operated patients. J Androl 1994;15(suppl):57S-62S.
69. Sasso F, Falabella R, Gentile G, Servello C, Gulino G: Blood-gas changes in the corpora cavernosa: metabolic and histomorphometric implications in patients with erectile dysfunction. J Urol 2003;169:2270-2274.
70. Akkus E, Ozkara H, Alici B, Demirkesen O, Akaydin A, Hattat H, Solok V: Incision and venous patch graft in the surgical treatment of penile curvature in Peyronie's disease. Eur Urol 2001;40:531-536.
71. Lue TF, El-Sakka AI: Venous patch graft for Peyronie's disease. I. Technique. J Urol 1998; 160(6 Pt 1):2047-2049.
72. Montorsi F, Salonia A, Maga T, Bua L, Guazzoni G, Barbieri L, Barbagli G, Chiesa R, Pizzini G, Rigatti P: Evidence-based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol 2000;163:1704-1708.
73. Herschorn S, Ordorica RC: Penile prosthesis insertion with corporeal reconstruction with synthetic vascular graft material. J Urol 1995;154:80-84.
74. Ghanem HM, Fahmy I, el-Meliegy A: Malleable penile implants without plaque surgery in the treatment of Peyronie's disease. Int J Impot Res 1998;10:171-173.
75. Austoni E, Colombo F, Romanò AL, Guarnieri A, Goumas IK, Cazzaniga A: Soft prosthesis implant and relaxing albugineal incision with saphenous grafting for surgical therapy of Peyronie's disease: a 5-year experience and long-term follow-up on 145 operated patients. Eur Urol 2005;47:223-229.
76. Wilson SK, Cleves MA, Delk JR: Long-term follow-up of treatment for Peyronie's disease: modeling the penis over an inflatable penile prosthesis. J Urol 2001;165:825-829.
77. Montorsi F, Salonia A, Maga T, Colombo R, Cestari A, Guazzoni G, Rigatti P: Reconfiguration of the severely fibrotic penis with a penile implant. J Urol 2001;166:1782-1786.